Works matching IS 22113428 AND DT 2019 AND VI 42 AND IP 4


Results: 11
    1

    The ERBB receptor inhibitor dacomitinib suppresses proliferation and invasion of pancreatic ductal adenocarcinoma cells.

    Published in:
    Cellular Oncology (2211-3428), 2019, v. 42, n. 4, p. 491, doi. 10.1007/s13402-019-00448-w
    By:
    • Momeny, Majid;
    • Esmaeili, Fatemeh;
    • Hamzehlou, Sepideh;
    • Yousefi, Hassan;
    • Javadikooshesh, Sepehr;
    • Vahdatirad, Vasimeh;
    • Alishahi, Zivar;
    • Mousavipak, Seyedeh H.;
    • Bashash, Davood;
    • Dehpour, Ahmad R.;
    • Tavangar, Seyyed M.;
    • Tavakkoly-Bazzaz, Javad;
    • Haddad, Peiman;
    • Kordbacheh, Farzaneh;
    • Alimoghaddam, Kamran;
    • Ghavamzadeh, Ardeshir;
    • Ghaffari, Seyed H.
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11